Shalby Ltd

Shalby Ltd's capital structure is characterized by a debt-to-equity ratio of 0.48, indicating a relatively conservative leverage position compared to the industry median. The company's liquidity is assessed as medium, with a current ratio of 1.45, suggesting it can cover its short-term obligations but with limited buffer. However, the company's operating cash flow is negative at -43.42 million INR, and free cash flow is also negative at -16.73 million INR, signaling potential liquidity constraints in the near term. Profitability metrics for Shalby Ltd show a return on equity (ROE) of 0.63% and a return on assets (ROA) of 0.37%, both of which are below the industry median for healthcare providers. The company's net income of 62.23 million INR is modest relative to its revenue of 10.87 billion INR, indicating low profitability. Gross profit of 4.52 billion INR represents 41.7% of revenue, which is in line with the industry average, but the operating margin of 6.4% is below the median for the sector. Geographically, Shalby Ltd's revenue is concentrated in India, with no disclosed international operations. The company's business is primarily driven by its domestic healthcare services and pharmaceuticals segments. There is no detailed breakdown of revenue by business segment in the latest financial data, but the company's primary activity is in pharmaceuticals. The company's growth trajectory is mixed. Revenue for the latest period is reported at 10.87 billion INR, but there is no year-over-year growth data provided. Analysts have assigned a mean price target of 192.00 INR, with a single "buy" recommendation and no "strong buy" or "hold" ratings. This suggests limited optimism about the company's near-term growth potential. The company's capital expenditure of -714.46 million INR indicates a significant investment in infrastructure or expansion, which could support future growth if it translates into higher revenue and profitability. Risk factors for Shalby Ltd include medium liquidity risk, as the company has negative net cash after subtracting total debt. The dilution risk is assessed as low, with no significant dilution expected in the near term. The company's debt load is manageable, with long-term debt of 4.76 billion INR, but the negative operating and free cash flows could pose challenges in maintaining debt serviceability. The risk assessment also highlights the need for improved cash flow generation to support ongoing operations and reduce reliance on external financing. Recent events and disclosures for Shalby Ltd include the latest financial results, which show a decline in operating and free cash flows. There are no recent filings or transcripts indicating major strategic shifts or regulatory changes. The company's financial performance and capital structure suggest a need for operational improvements to enhance profitability and cash flow generation.